The Indian Pharmaceutical Market (IPM) recorded 8.1% YoY growth in August 2025, up from 7.1% in July, driven by strong demand in chronic therapies like cardiac, anti-diabetic, and CNS drugs. Acute therapies grew slower, while GLP-1 sales surged 97% MoM. HDFC Securities projects FY26 IPM growth at 8-9%, led by chronic segments and new launches.